These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 32810579
21. Insights into the Release Mechanisms of ITZ:HPMCAS Amorphous Solid Dispersions: The Role of Drug-Rich Colloids. Nunes PD, Pinto JF, Henriques J, Paiva AM. Mol Pharm; 2022 Jan 03; 19(1):51-66. PubMed ID: 34919407 [Abstract] [Full Text] [Related]
22. Elucidating the effect of crystallization on drug release from amorphous solid dispersions in soluble and insoluble carriers. Ojo AT, Ma C, Lee PI. Int J Pharm; 2020 Dec 15; 591():120005. PubMed ID: 33132149 [Abstract] [Full Text] [Related]
23. Amorphous Solid Dispersion Formation for Enhanced Release Performance of Racemic and Enantiopure Praziquantel. Polyzois H, Nguyen HT, Roberto de Alvarenga Junior B, Taylor LS. Mol Pharm; 2024 Oct 07; 21(10):5285-5296. PubMed ID: 39292641 [Abstract] [Full Text] [Related]
25. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives. Xie T, Taylor LS. Mol Pharm; 2016 Mar 07; 13(3):873-84. PubMed ID: 26791934 [Abstract] [Full Text] [Related]
26. Viewing Molecular and Interface Interactions of Curcumin Amorphous Solid Dispersions for Comprehending Dissolution Mechanisms. Li J, Wang X, Li C, Fan N, Wang J, He Z, Sun J. Mol Pharm; 2017 Aug 07; 14(8):2781-2792. PubMed ID: 28661679 [Abstract] [Full Text] [Related]
28. Comprehensive evaluation of polymer types and ratios in Spray-Dried Dispersions: Compaction, Dissolution, and physical stability. Yu D, Nie H, Hoag SW. Int J Pharm; 2024 Jan 25; 650():123674. PubMed ID: 38061497 [Abstract] [Full Text] [Related]
29. Moisture-Induced Amorphous Phase Separation of Amorphous Solid Dispersions: Molecular Mechanism, Microstructure, and Its Impact on Dissolution Performance. Chen H, Pui Y, Liu C, Chen Z, Su CC, Hageman M, Hussain M, Haskell R, Stefanski K, Foster K, Gudmundsson O, Qian F. J Pharm Sci; 2018 Jan 25; 107(1):317-326. PubMed ID: 29107047 [Abstract] [Full Text] [Related]
30. Does Media Choice Matter When Evaluating the Performance of Hydroxypropyl Methylcellulose Acetate Succinate-Based Amorphous Solid Dispersions? Bapat P, Paul S, Thakral NK, Tseng YC, Taylor LS. Mol Pharm; 2023 Nov 06; 20(11):5714-5727. PubMed ID: 37751517 [Abstract] [Full Text] [Related]
32. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type. Jackson MJ, Kestur US, Hussain MA, Taylor LS. Mol Pharm; 2016 Jan 04; 13(1):223-31. PubMed ID: 26618718 [Abstract] [Full Text] [Related]
36. Comparative study of the potential of poly(2-ethyl-2-oxazoline) as carrier in the formulation of amorphous solid dispersions of poorly soluble drugs. Boel E, Smeets A, Vergaelen M, De la Rosa VR, Hoogenboom R, Van den Mooter G. Eur J Pharm Biopharm; 2019 Nov 04; 144():79-90. PubMed ID: 31499162 [Abstract] [Full Text] [Related]
38. Improved dissolution of an enteric polymer and its amorphous solid dispersions by polymer salt formation. Qi Q, Taylor LS. Int J Pharm; 2022 Jun 25; 622():121886. PubMed ID: 35661745 [Abstract] [Full Text] [Related]